Detalhe da pesquisa
1.
The impact of genetic variations in sofosbuvir metabolizing enzymes and innate immunity mediators on treatment outcome in HCV-infected patients.
Microb Pathog
; 162: 105311, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34843922
2.
Relation between microRNA-21, transforming growth factor ß and response to treatment among chronic hepatitis C patients.
J Med Virol
; 91(12): 2166-2173, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31368531
3.
Can brucellosis influence the course of chronic hepatitis C in dual infection?
Arch Virol
; 158(3): 543-7, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23124842
4.
Genetic polymorphisms of Endoplasmic reticulum amino peptidase 1 (ERAP1) and Interferon lambda 4 (IFN-λ4) in Egyptian patients with type 1 diabetes mellitus.
Egypt J Immunol
; 30(1): 116-124, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36592387
5.
Relevance of HLA-DP/DQ and INF-λ4 Polymorphisms to COVID-19 Outcomes.
Br J Biomed Sci
; 80: 11044, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36743382
6.
Association of interferon-γ inducible protein-10 pretreatment level and sustained virological response in HCV-positive Egyptian patients.
Ann Clin Lab Sci
; 44(2): 167-72, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24795055